Last updated 2:00AM ET
June 18, 2013
Search NewsRoom
Search NewsRoom
go
Advanced Search
PRI's The World - Jun 17, 2013 Iran's new president calls for engagement with other countries. We'll compare and contrast new leader Hassan Rouhani with outgoing President Mahmoud Ahmadinejad. Also, we hear about a project in Qatar seeking new ways to grow crops in the crops in the hot and arid desert. Plus, a scandal in Japan over "juiced" baseballs.
PRI's The World - Jun 14, 2013 Election day in Iran as voters decide who should replace President Mahmoud Ahmadinejad. Plus, protests erupt in Brazil as price hike on buses irks riders. And, collecting sounds from the Eiffel Tower.
PRI's The World - Jun 13, 2013 The United Nations ups the documented toll in Syria to nearly 93,000 since the start of the war. Also, "What's for Lunch" in Uganda? Scientists there hope to introduce a disease-resistant version of the staple crop, cassava - a genetically modified one. And Mozart's violin takes center stage in the Geo Quiz.
Tools
Tools
Weather
Current Conditions
78°
Philadelphia
Get your local weather
go
World Headlines
Deadly blast before Afghan handover A bomb explodes in western Kabul on the day Nato is due to formally hand over command of security responsibilities to Afghan forces.
Protests spread throughout Brazil As many as 200,000 people marched through Brazil's biggest cities, as protests over public transport costs and the expense of the World Cup spread.
G8 leaders to focus on tax and trade Tax, trade and transparency are expected to dominate discussions at the G8 summit, with leaders said to be close to agreeing a statement on Syria.
Should the NSA send you a check when they wiretap you?
Computer scientist Jaron Lanier has a market solution for the NSA's wiretapping needs -- and it involves taking out the agency's checkbook.
Why do actors in France get paid so much? Subsidies
French win concession in Transatlantic trade negotiations.
Court says deals to protect drug patents can be challenged
Makers of patented drugs sometimes pay generic drug makers not to copy their drugs when they go off patent, allowing them to keep charging high prices. The U.S. Supreme Court says the FTC can challenge such deals.
NPR Nation/World News